Journal of Orthopedic Oncology
Open Access

Spinal cord tumors are abnormal growths that develop within or near the spinal cord, which plays a central role in transmitting messages between the brain and the rest of the body. Though spinal cord tumors are uncommon, they can cause severe neurological deficits, ranging from mild pain and weakness to paralysis and loss of bodily functions. Because these tumors affect the spinal cord’s delicate structure, their management often requires a multidisciplinary approach [1]. Understanding the different types of spinal cord tumors, the factors contributing to their development, and the latest treatment options is essential for providing effective care. This review article aims to provide a comprehensive overview of spinal cord tumors, focusing on their causes, classifications, diagnostic methods, and the most current treatment approaches [2].

Causes of Spinal Cord Tumors

The exact cause of most spinal cord tumors remains unclear, but several factors are thought to contribute to their development.

Genetic Factors: Some spinal cord tumors are linked to inherited genetic conditions such as neurofibromatosis, von Hippel-Lindau disease, and Li-Fraumeni syndrome, which increase the likelihood of tumor development.

Environmental Factors: Exposure to certain environmental factors, such as radiation, may increase the risk of developing spinal cord tumors, although this is less common [3].

Age and Gender: Spinal cord tumors are more frequently diagnosed in adults than children, with men being slightly more likely to develop certain types of tumors, such as schwannomas and meningiomas.

Types of Spinal Cord Tumors

Spinal cord tumors can be classified based on their location (intraspinal or extramedullary), histology, and the type of tissue from which they originate. The primary types of spinal cord tumors are:

Intradural Extramedullary Tumors

Meningiomas: Tumors that arise from the meninges, the protective membranes surrounding the brain and spinal cord. These tumors are often benign and slow-growing.

Schwannomas: Originating from Schwann cells that produce myelin, these tumors are typically benign and often present as well-circumscribed masses [4].

Neurofibromas: Another benign tumor that grows from nerve fibers, commonly associated with neurofibromatosis.

Intramedullary Tumors

Ependymomas: Tumors arising from the ependymal cells lining the ventricles of the brain and spinal cord. Ependymomas account for a significant proportion of spinal cord tumors in children.

Astrocytomas: These tumors develop from astrocytes, a type of glial cell. Astrocytomas can range from low-grade (benign) to high-grade (malignant).

Extradural Tumors

Metastatic Tumors: Tumors that have spread from other parts of the body, most commonly from cancers of the lung, breast, or prostate, can affect the spine, leading to secondary spinal cord tumors [5].

Clinical Presentation

Symptoms of spinal cord tumors can vary significantly depending on the tumor's size, location, and whether it compresses nearby nerves or tissues. Common symptoms include:

Back pain, which can be severe and worsen over time. Neurological deficits, such as weakness, numbness, or tingling in the limbs, difficulty walking, or loss of bladder or bowel control. Scoliosis or other spinal deformities, especially in pediatric patients. Radicular pain, radiating pain from nerve root compression. The slow onset of symptoms often results in delayed diagnosis, emphasizing the need for early recognition and intervention [6].

Diagnosis

The diagnosis of spinal cord tumors involves a combination of clinical evaluation, imaging, and sometimes biopsy:

Magnetic Resonance Imaging (MRI): MRI is the most effective imaging tool for detecting spinal cord tumors, providing detailed images of both soft tissues and bones.

Computed Tomography (CT): CT scans may be used to assess bone involvement, especially in cases where there is concern about metastasis or bone destruction [7].

Myelography: This technique involves injecting a contrast dye into the spinal canal to highlight any abnormalities, which can be useful in cases where MRI is inconclusive.

Biopsy: In some cases, a biopsy may be performed to determine the tumor’s histological type and help guide treatment decisions.

Treatment Options

Treatment for spinal cord tumors depends on the tumor’s type, size, location, and whether it is benign or malignant. The main treatment modalities include:

Surgical Removal: Surgical resection is often the primary treatment for accessible spinal cord tumors, especially benign tumors. The goal is to remove as much of the tumor as possible without causing further neurological damage. However, surgery may not always be feasible for tumors located near critical areas of the spinal cord [8].

Radiotherapy: For tumors that cannot be completely removed surgically or for malignant tumors, radiation therapy is often used. Stereotactic radiosurgery is a non-invasive option that delivers high doses of radiation to the tumor while minimizing damage to surrounding tissues [9].

Chemotherapy: In cases of malignant tumors, particularly high-grade gliomas or metastatic tumors, chemotherapy may be used either alone or in combination with surgery and radiation therapy.

Supportive Care: Rehabilitation, pain management, and physical therapy play critical roles in improving the quality of life for patients with spinal cord tumors, especially those who experience permanent neurological deficits [10].

Conclusion

Spinal cord tumors, although relatively rare, can have a profound impact on a person’s life. Early detection through imaging and clinical evaluation is crucial for effective treatment, particularly when surgical resection is feasible. The multidisciplinary approach to managing these tumors, combining surgery, radiation, and supportive care, provides the best chance for improving patient outcomes.Ongoing research into the genetic causes, early biomarkers, and novel treatment strategies holds promise for better management of spinal cord tumors in the future. It is essential for healthcare providers to stay informed about the latest advancements in diagnosis and treatment to offer the most effective care to patients with spinal cord tumors.

1. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM (2002) Response inhibition deficits in obsessive–compulsive disorder. Psychiatry Res 110: 165-174.

Indexed at, Google Scholar, Crossref

2. Bestelmeyer PE, Phillips LH, Crombiz C, Benson P, Clair DS, et al. (2009) The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies. Psychiatry res 169: 212-219.

Indexed at, Google Scholar, Crossref

3. Chambers CD, Bellgrove MA, Stokes MG, Henderson TR, Garavan H, et al. (2006) Executive “brake failure” following deactivation of human frontal lobe. J Cogn Neurosci 18: 444-455.

Indexed at, Google Scholar, Crossref

4. Badcock JC, Michie PT, Johnson L, Combrinck J (2002) Acts of control in schizophrenia: dissociating the components of inhibition. Psychol Med 32: 287-297.

Indexed at, Google Scholar, Crossref

5. Bleuler E (1958) Dementia praecox or the group of schizophrenias, New York (International

Universities Press) 1958.
Google Scholar

6. Bellgrove MA, Chambers CD, Vance A, Hall N, Karamitsios M, et al. (2006) Lateralized deficit of response inhibition in early-onset schizophrenia. Psychol Med 36: 495-505.

Indexed at, Google Scholar, Crossref

7. Carter CS, Barch DM (2007) Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull 33: 1131-1137.

Indexed at, Google Scholar, Crossref

8. Aron AR (2011) From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol psychiatry 69: e55-e68.

Indexed at, Google Scholar, Crossref

9. Blasi G, Goldberg TE, Weickert T, Das S, Kohn P, et al. (2006) Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neurosci 23: 1658-1664.

Indexed at, Google Scholar, Crossref

10. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP, et al. (1992) Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12: 924-929.

Indexed at, Google Scholar, Crossref